Sitemap

Publications

• 4-Aminobiphenyl N-glucuronidation by liver microsomes: optimization of the reaction conditions and characterization of the UDP-glucuronosyltransferase isoforms. (July 14, 2025)
• A Bayesian back-calculation method to estimate the risk of bovine spongiform encephalopathy (BSE) in Canada during the period 1996-2011. (July 14, 2025)
• A Bayesian modelling framework for tornado occurrences in North America. (October 3, 2025)
• A beta-helical antifreeze protein isoform with increased activity. Structural and functional insights. (July 14, 2025)
• A carcinogenicity study of commercial saccharin in the rat. (June 1, 1975)
• A case-control analysis of nonsteroidal anti-inflammatory drugs and Alzheimer's disease: are they protective? (July 14, 2025)
• A case-control study of toenail selenium and cancer of the breast, colon, and prostate. (July 14, 2025)
• A class of non-linear exposure-response models suitable for health impact assessment applicable to large cohort studies of ambient air pollution. (July 14, 2025)
• A combined analysis of North American case-control studies of residential radon and lung cancer. (April 1, 2006)
• A comparison of methods for estimating the benchmark dose based on overdispersed data from developmental toxicity studies. (June 1, 1998)
• A comparison of methods for the analysis of recurrent health outcome data with environmental covariates. (July 14, 2025)
• A comparison of statistical methods for low dose extrapolation utilizing time-to-tumor data. (July 14, 2025)
• A comprehensive evaluation of the potential health risks associated with occupational and environmental exposure to styrene. (July 14, 2025)
• A decision tree approach to screen drinking water contaminants for multiroute exposure potential in developing guideline values. (October 3, 2025)
• A family of expressed antifreeze protein genes from the moth, Choristoneura fumiferana. (January 1, 2002)
• A framework for the next generation of risk science. (August 1, 2014)
• A Framework that Considers the Impacts of Time, Cost, and Uncertainty in the Determination of the Cost Effectiveness of Toxicity-Testing Methodologies. (April 1, 2022)
• A literature review: the cardiovascular effects of exposure to extremely low frequency electromagnetic fields. (August 1, 2009)
• A longitudinal analysis of early lung function trajectory in survivors of childhood Hodgkin lymphoma. (January 1, 2023)
• A meta-analysis of evidence for hormesis in animal radiation carcinogenesis, including a discussion of potential pitfalls in statistical analyses to detect hormesis. (July 14, 2025)
• A meta-analysis of observational studies of the association between chronic occupational exposure to lead and amyotrophic lateral sclerosis. (December 1, 2014)
• A model-free approach to low-dose extrapolation. (January 1, 1991)
• A multi-level analysis of risk factors for Schistosoma japonicum infection in China. (November 1, 2009)
• A psychosocial risk assessment and management framework to enhance response to CBRN terrorism threats and attacks. (July 14, 2025)
• A randomized controlled trial comparing subscapularis tenotomy with peel in anatomic shoulder arthroplasty. (February 1, 2020)
• A randomized, double-blind sham-controlled trial on the efficacy of arthroscopic tennis elbow release for the management of chronic lateral epicondylitis. (July 14, 2025)
• A Retrospective Case-Control Study to Identify Predictors of Unplanned Admission to Pediatric Intensive Care Within 24 Hours of Hospitalization. (July 1, 2019)
• A risk-based classification scheme for genetically modified foods. I: Conceptual development. (December 1, 2008)
• A risk-based classification scheme for genetically modified foods. II: Graded testing. (December 1, 2008)
• A risk-based classification scheme for genetically modified foods. III: Evaluation using a panel of reference foods. (December 1, 2008)
• A Scoping Review to Map Empirical Evidence Regarding Key Domains and Questions in the Clinical Pathway of Delirium in Palliative Care. (March 1, 2019)
• A signal-to-noise crossover dose as the point of departure for health risk assessment. (December 1, 2011)
• A simple data transformation for estimating benchmark doses in developmental toxicity experiments. (February 1, 1995)
• A single point mutation in Drosophila dihydrofolate reductase confers methotrexate resistance to a transgenic CHO cell line. (August 1, 2003)
• A stochastic model of the bovine spongiform encephalopathy epidemic in Canada. (July 14, 2025)
• A systematic review and meta-analysis of childhood leukemia and parental occupational pesticide exposure. (October 1, 2009)
• A time-series study of air pollution, socioeconomic status, and mortality in Vancouver, Canada. (November 1, 2003)
• A unified approach to risk assessment for cancer and noncancer endpoints based on benchmark doses and uncertainty/safety factors. (April 1, 1999)
• A unified approach to risk characterization. (July 14, 2025)
• A validation sampling approach for consistent estimation of adverse drug reaction risk with misclassified right-censored survival data. (July 14, 2025)
• A value of information framework for assessing the trade-offs associated with uncertainty, duration, and cost of chemical toxicity testing. (March 1, 2023)
• A Weibull model for the estimation of tumorigenic potency. (June 1, 1993)
• Active surveillance in Canadian men with low-grade prostate cancer. (July 14, 2025)
• Acute effects of ambient ozone on mortality in Europe and North America: results from the APHENA study. (July 14, 2025)
• Acute effects of ambient particulate matter on mortality in Europe and North America: results from the APHENA study. (November 1, 2008)
• Additive and multiplicative relative risk in the two-stage clonal expansion model of carcinogenesis. (September 1, 1991)
• Adjusting for Berkson error in exposure in ordinary and conditional logistic regression and in Poisson regression. (July 14, 2025)
• Adjusting for measurement error in the Cox proportional hazards regression model. (July 14, 2025)
• Adjusting for temporal variation in the analysis of parallel time series of health and environmental variables. (July 14, 2025)
• Adolescent injuries in Canada: findings from the Canadian community health survey, 2000-2001. (December 1, 2006)
• Adult Utilization of Psychiatric Drugs and Differences by Sex, Age, and Race. (July 14, 2025)
• Advancements in Life Cycle Human Exposure and Toxicity Characterization. (December 1, 2018)
• Aetiology of extracranial carotid free-floating thrombus in a prospective multicentre cohort. (June 1, 2023)
• Air pollution and health: a European and North American approach (APHENA). (October 1, 2009)
• Air pollution and public health: a guidance document for risk managers. (July 14, 2025)
• Air Pollution and Respiratory Hospital Admissions in Kuwait: The Epidemiological Applicability of Predicted PM(2.5) in Arid Regions. (July 14, 2025)
• Air pollution: health effects and assessment of exposure levels. (July 14, 2025)
• Air quality risk assessment and management. (July 14, 2025)
• Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers. (December 1, 2010)
• Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, Canada, France, Israel, and New Zealand. (May 1, 2013)
• Ambient Air Pollution and Cancer Mortality in the Cancer Prevention Study II. (July 14, 2025)
• Ambient air pollution and population health: overview. (July 14, 2025)
• AMESFIT: a microcomputer program for fitting linear-exponential dose-response models in the Ames Salmonella assay. (July 14, 1993)
• An analytical framework for delirium research in palliative care settings: integrated epidemiologic, clinician-researcher, and knowledge user perspectives. (August 1, 2014)
• An exact representation for the generating function for the Moolgavkar-Venzon-Knudson two-stage model of carcinogenesis with stochastic stem cell growth. (July 14, 2025)
• An exposure-response curve for copper excess and deficiency. (October 1, 2010)
• An overview of the association between allergy and cancer. (July 14, 2025)
• An overview of the North American residential radon and lung cancer case-control studies. (April 1, 2006)
• An overview of the report: correlation between carcinogenic potency and the maximum tolerated dose: implications for risk assessment. (August 1, 1993)
• Analysis of antifreeze proteins within spruce budworm sister species. (June 1, 2005)
• Analysis of intervention effectiveness using early outbreak transmission dynamics to guide future pandemic management and decision-making in Kuwait. (July 14, 2025)
• Analysis of key characteristics of human carcinogens. (July 14, 2025)
• Analysis of multiple exposures: an empirical comparison of results from conventional and semi-bayes modeling strategies. (January 1, 2010)
• Analysis of the Healthcare MERS-CoV Outbreak in King Abdulaziz Medical Center, Riyadh, Saudi Arabia, June-August 2015 Using a SEIR Ward Transmission Model. (July 14, 2025)
• Analysis of tumour site concordance. (July 14, 2025)
• Aortic Valve Intervention During Aortic Root Surgery in Children: A Systematic Review. (September 1, 2020)
• Application of a framework for the selection of an appropriate occupational exposure limit for manganese. (January 1, 2017)
• Applications of mathematical modeling in managing the spread of chronic wasting disease (CWD) in wild deer under alternative harvesting scenarios. (July 14, 2025)
• Applications of multinomial dose-response models in developmental toxicity risk assessment. (August 1, 1994)
• Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment. (December 1, 1994)
• Are the apparent effects of cigarette smoking on lung and bladder cancers due to uncontrolled confounding by occupational exposures? (January 1, 1994)
• Aromatic amines and biomarkers of human exposure. (November 1, 2003)
• Assessing and managing risks arising from exposure to endocrine-active chemicals. (March 1, 2008)
• Assessing the health risks of benzene: a report on the benzene state-of-the-science workshop. (November 1, 2000)
• Assessing the impact of different assumptions on the size of a Mixture Assessment Factor (MAF) for chemical mixtures in surface waters using data from three recent monitoring studies. (July 14, 2025)
• Assessing the State of Knowledge Regarding the Effectiveness of Interventions to Contain Pandemic Influenza Transmission: A Systematic Review and Narrative Synthesis. (July 14, 2025)
• Assessment and management of residential radon health risks: a report from the health Canada radon workshop. (April 1, 2006)
• Assessment of Patterns of Potentially Unsafe Use of Zolpidem. (July 14, 2025)
• Association between air pollution and multiple respiratory hospitalizations among the elderly in Vancouver, Canada. (December 1, 2006)
• Association between aluminum in drinking water and incident Alzheimer's disease in the Canadian Study of Health and Aging cohort. (March 1, 2021)
• Association between ambient carbon monoxide levels and hospitalizations for congestive heart failure in the elderly in 10 Canadian cities. (March 1, 1997)
• Association between change of health care providers and pregnancy exposure to FDA category C, D and X drugs. (July 14, 2025)
• Association Between Early Participation in Physical Activity Following Acute Concussion and Persistent Postconcussive Symptoms in Children and Adolescents. (July 14, 2025)
• Association between exclusive breastfeeding and postpartum post-traumatic stress disorder. (July 14, 2025)
• Association between gaseous ambient air pollutants and adverse pregnancy outcomes in Vancouver, Canada. (November 1, 2003)
• Association between labetalol use for hypertension in pregnancy and adverse infant outcomes. (April 1, 2014)
• Association between maternal exposure to ambient air pollutants during pregnancy and fetal growth restriction. (August 1, 2007)
• Association between medication-related adverse events and non-elective readmission in acute ischemic stroke. (July 14, 2025)
• Association between ondansetron use and symptom persistence in children with concussions: A 5P substudy. (March 1, 2019)
• Association between ozone and hospitalization for acute respiratory diseases in children less than 2 years of age. (July 14, 2025)
• Association between ozone and hospitalization for respiratory diseases in 16 Canadian cities. (January 1, 1997)
• Association between ozone and respiratory admissions among children and the elderly in Vancouver, Canada. (November 1, 2003)
• Association between particulate air pollution and first hospital admission for childhood respiratory illness in Vancouver, Canada. (January 1, 2004)
• Association between particulate- and gas-phase components of urban air pollution and daily mortality in eight Canadian cities. (July 14, 2025)
• Association of allergic diseases and epilepsy with risk of glioma, meningioma and acoustic neuroma: results from the INTERPHONE international case-control study. (May 1, 2022)
• Association of maternal postpartum depression symptoms with infant neurodevelopment and gut microbiota. (July 14, 2025)
• Association of treatments for acute appendicitis with pregnancy outcomes in the United States from 2000 to 2016: Results from a multi-level analysis. (July 14, 2025)
• Associations between ambient particulate sulfate and admissions to Ontario hospitals for cardiac and respiratory diseases. (July 14, 2025)
• Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease. (July 14, 2025)
• Associations Between Cardiovascular Events and Nonergot Dopamine Agonists in Parkinson's Disease. (July 14, 2025)
• Associations between cigarette smoking and each of 21 types of cancer: a multi-site case-control study. (June 1, 1995)
• Associations between polysomnography measurements and postoperative adverse respiratory events in children with neuromuscular disease. (July 14, 2025)
• Associations between several sites of cancer and occupational exposure to benzene, toluene, xylene, and styrene: results of a case-control study in Montreal. (August 1, 1998)
• Asthma and the risk of hospitalization in Canada : the role of socioeconomic and demographic factors. (March 1, 2001)
• Authors' response to the Comments from S.M.J. Mortazavi regarding: "Occupational exposure to high-frequency electromagnetic fields and brain tumor risk in the INTEROCC study: An individualized assessment approach". (December 1, 2018)
• Bayesian model averaging in time-series studies of air pollution and mortality. (July 14, 2025)
• Benchmark doses for developmental toxicants. (July 14, 2025)
• Berkson error adjustment and other exposure surrogates in occupational case-control studies, with application to the Canadian INTEROCC study. (May 1, 2018)
• Beta-blockers increase the risk of being born small for gestational age or of being institutionalised during infancy. (August 1, 2014)
• Beyond the RfD: Broad Application of a Probabilistic Approach to Improve Chemical Dose-Response Assessments for Noncancer Effects. (June 1, 2018)
• Bias due to aggregation of individual covariates in the Cox regression model. (July 14, 2025)
• Bias in the case-only design applied to studies of gene-environment and gene-gene interaction: a systematic review and meta-analysis. (October 1, 2011)
• Bioaccumulation and locomotor effects of manganese phosphate/sulfate mixture in Sprague-Dawley rats following subchronic (90 days) inhalation exposure. (July 14, 2025)
• Biologically based analysis of lung cancer incidence in a large Canadian occupational cohort with low-dose ionizing radiation exposure, and comparison with Japanese atomic bomb survivors. (June 1, 2006)
• Biologically based risk assessment model for cyclophosphamide hematotoxicity in animal species: concluding comments. (November 1, 2000)
• Biomarkers for occupational manganese exposure. (September 1, 2022)
• Biomarkers of environmental manganese exposure. (April 1, 2022)
• Blood transfusion and hemostatic agents used during radical cystectomy. (July 14, 2025)
• Bone cancers in Mayak workers. (September 1, 2000)
• Bovine spongiform encephalopathy and the safety of milk from Canadian dairy cattle. (July 14, 2025)
• Brain tumours and cigarette smoking: analysis of the INTERPHONE Canada case-control study. (July 14, 2025)
• Breast cancer risk in relation to alcohol consumption and BRCA gene mutations--a case-only study of gene-environment interaction. (July 14, 2025)
• Building knowledge of NAMs through risk science. (November 1, 2024)
• Burden of neurological conditions in Canada. (July 1, 2017)
• Can shape analysis differentiate free-floating internal carotid artery thrombus from atherosclerotic plaque in patients evaluated with CTA for stroke or transient ischemic attack? (March 1, 2014)
• Canadian National Dose Registry of radiation workers: overview of research from 1951 through 2007. (July 14, 2025)
• Cancer mortality among US men and women with asthma and hay fever. (July 14, 2025)
• Cancer mortality risk among workers at the Mayak nuclear complex. (June 1, 2003)
• Cancer risk assessment with intermittent exposure. (December 1, 1992)
• Cancer risk due to occupational exposure to polycyclic aromatic hydrocarbons. (September 1, 1995)
• Cancer risks due to occupational exposure to formaldehyde: results of a multi-site case-control study in Montreal. (July 14, 2025)
• Carcinogenic mixtures. (March 1, 1992)
• Carcinogenic potency and interspecies extrapolation. (July 14, 1990)
• Carcinogenic risk assessment of complex mixtures. (October 1, 1989)
• Carcinogenic risk assessment with time-dependent exposure patterns. (December 1, 1988)
• Carcinogenic risk assessment: a guide to the literature. (June 1, 1981)
• Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke: shape of the exposure-response relationship. (July 14, 2025)
• Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. (July 14, 2025)
• Case-control study of radon and lung cancer in New Jersey. (July 14, 2025)
• Case-control study of residential radon and lung cancer in Winnipeg, Manitoba, Canada. (July 14, 2025)
• Cell phone use and the risk of glioma: are case-control study findings consistent with Canadian time trends in cancer incidence? (September 1, 2021)
• Challenges in the expression of disulfide bonded, threonine-rich antifreeze proteins in bacteria and yeast. (May 1, 2006)
• Characteristics of the cohort of workers at the Mayak nuclear complex. (October 1, 1999)
• Characterization of antifreeze protein gene expression in summer spruce budworm larvae. (March 1, 2006)
• Characterization of uncertainty and variability in residential radon cancer risks. (July 14, 1999)
• Chlorination disinfection by-products and pancreatic cancer risk. (April 1, 2005)
• Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. (July 14, 2025)
• Cigarette smoking and cancer risk: modeling total exposure and intensity. (July 14, 2025)
• Clinical predictors of nonadherence to positive airway pressure therapy in children: a retrospective cohort study. (July 14, 2025)
• Clinical presentation of young people (10-24 years old) with brain tumors: results from the international MOBI-Kids study. (April 1, 2020)
• Cloning and characterization of a member of the Hsp70 gene family from Locusta migratoria, a highly thermotolerant insect. (July 14, 2025)
• Co-mutagenic activity of arsenic and benzo[a]pyrene in mouse skin. (July 14, 2025)
• Cobalt and chromium levels in blood and urine following hip resurfacing arthroplasty with the Conserve Plus implant. (May 1, 2011)
• Cohort cancer incidence among pulp and paper mill workers in British Columbia. (April 1, 2001)
• Cohort mortality study of pulp and paper mill workers in British Columbia, Canada. (July 14, 2025)
• Colloquium statement: strategic policy directions for air quality management. (July 14, 2025)
• Comments on "Children's health, susceptibility, and regulatory approaches to reducing risk from chemical carcinogens". (September 1, 2001)
• Community-based screening and triage connecting First Nations children and youth to local supports: a cross-sectional study. (July 14, 2025)
• Comparative, cross-sectional study of the format, content and timing of medication safety letters issued in Canada, the USA and the UK. (July 14, 2025)
• Comparing the Health Effects of Ambient Particulate Matter Estimated Using Ground-Based versus Remote Sensing Exposure Estimates. (April 1, 2017)
• Comparison of Points of Departure for Health Risk Assessment Based on High-Throughput Screening Data. (April 1, 2017)
• Comparison of time series and case-crossover analyses of air pollution and hospital admission data. (December 1, 2003)
• Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014. (June 1, 2016)
• Computed tomography angiography intraluminal filling defect is predictive of internal carotid artery free-floating thrombus. (January 1, 2014)
• Conceptualizing the healthscape: contributions of time geography, location technologies and spatial ecology to place and health research. (March 1, 2010)
• Concomitant use of statins and sodium-glucose co-transporter 2 inhibitors and the risk of myotoxicity reporting: A disproportionality analysis. (August 1, 2023)
• Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans. (July 14, 2025)
• Conditional validation sampling for consistent risk estimation with binary outcome data subject to misclassification. (February 1, 2019)
• Controlling for potential confounding by occupational exposures. (July 14, 2025)
• Copper and human health: biochemistry, genetics, and strategies for modeling dose-response relationships. (July 14, 2025)
• Corrigendum to: Diagnostic radiological examinations and risk of intracranial tumours in adults-findings from the interphone study. (July 14, 2025)
• Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011. (July 14, 2025)
• Creating enriched training sets of eligible studies for large systematic reviews: the utility of PubMed's Best Match algorithm. (July 14, 2025)
• Critical review of the association between perineal use of talc powder and risk of ovarian cancer. (December 1, 2019)
• Current trends in toxicological risk assessment: perspectives from the committee on toxicology. (July 14, 2025)
• Dabigatran, bleeding, and the regulators. (July 14, 2025)
• Data on systematic review and meta-analysis of epidemiologic evidence on the association between perineal use of talc powder and risk of ovarian cancer. (April 1, 2020)
• Database of radiogenic cancer in experimental animals exposed to low doses of ionizing radiation. (July 14, 2025)
• Database-calibrated toxicity values for human health assessment based on existing toxicology data for one thousand chemicals. (October 3, 2025)
• Decreases in occupational exposure to ionizing radiation among Canadian dental workers. (January 1, 2005)
• Dental amalgam and multiple sclerosis: a case-control study in Montreal, Canada. (August 1, 1998)
• Derivation of biomonitoring equivalent for inorganic tin for interpreting population-level urinary biomonitoring data. (November 1, 2016)
• Derivation of whole blood biomonitoring equivalents for lithium for the interpretation of biomonitoring data. (March 1, 2020)
• Derivation of whole blood biomonitoring equivalents for titanium for the interpretation of biomonitoring data. (July 1, 2020)
• Detection of prion protein in urine-derived injectable fertility products by a targeted proteomic approach. (July 14, 2025)
• Determinants of breast-feeding and weaning in Alberta, Canada. (November 1, 2004)
• Determinants of influenza non-vaccination among Canadian children: insights from a nationwide survey. (July 14, 2025)
• Determinants of mobile phone output power in a multinational study: implications for exposure assessment. (October 1, 2009)
• Determinants of neurological disease: Synthesis of systematic reviews. (July 1, 2017)
• Determining "safe" levels of exposure: safety factors or mathematical models? (June 1, 1984)
• Developing tools for defining and establishing pathways of toxicity. (May 1, 2015)
• Development of a copper database for exposure-response analysis. (July 14, 2025)
• Development of a database on key characteristics of human carcinogens. (July 14, 2025)
• Development of a database on tumors and tumor sites in humans and in experimental animals for 'Group 1 agents identified through volume 109 of the IARC Monographs. (July 14, 2025)
• Development of a physiologically based model to describe the pharmacokinetics of methylphenidate in juvenile and adult humans and nonhuman primates. (July 14, 2025)
• Development of a risk-ranking framework to evaluate potential high-threat microorganisms, toxins, and chemicals in food. (March 1, 2009)
• Development of a wearable global positioning system for place and health research. (July 14, 2025)
• Development of acute exposure guideline levels for airborne exposures to hazardous substances. (April 1, 2004)
• Development of an Evidence-Based Risk Assessment Framework. (July 14, 2025)
• Development of biomonitoring equivalents for barium in urine and plasma for interpreting human biomonitoring data. (June 1, 2017)
• Diagnosis of manganism and manganese neurotoxicity: A workshop report. (July 14, 2025)
• Diagnostic radiological examinations and risk of intracranial tumours in adults-findings from the Interphone Study. (July 14, 2025)
• Dietary intake of lycopene is associated with reduced pancreatic cancer risk. (March 1, 2005)
• Dietary patterns and risk of pancreatic cancer. (July 14, 2025)
• Dietary risk factors for testicular carcinoma. (July 14, 2025)
• Differentiating Carotid Free-Floating Thrombus From Atheromatous Plaque Using Intraluminal Filling Defect Length on CTA: A Validation Study. (July 14, 2025)
• Dihydrofolate reductase of Drosophila. Cloning and expression of a gene with a rare transcript. (July 14, 2025)
• Direct oral anticoagulants and oesophageal disorders: a pharmacovigilance analysis. (July 1, 2020)
• Disaster and emergency management: Canadian nurses' perceptions of preparedness on hospital front lines. (July 14, 2025)
• Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom. (April 1, 2023)
• Does leptin play a role in obesity-asthma relationship? (May 1, 2009)
• Does neck-to-waist ratio predict obstructive sleep apnea in children? (July 14, 2025)
• Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness. (June 1, 2002)
• Dose-response relationships in carcinogenesis. (July 14, 1992)
• Effect of N-glucuronidation on urinary bladder genotoxicity of 4-aminobiphenyl in male and female mice. (September 1, 2006)
• Effect of short-term exposure to gaseous pollution on asthma hospitalisation in children: a bi-directional case-crossover analysis. (January 1, 2003)
• Effect of short-term exposure to low levels of gaseous pollutants on chronic obstructive pulmonary disease hospitalizations. (September 1, 2005)
• Effectiveness of personal protective measures in reducing pandemic influenza transmission: A systematic review and meta-analysis. (September 1, 2017)
• Effects of low ambient levels of ozone and sulfates on the frequency of respiratory admissions to Ontario hospitals. (May 1, 1994)
• Effects of over-the-counter analgesic use on reproductive hormones and ovulation in healthy, premenopausal women. (July 1, 2015)
• Effects of vaginal microbiota transfer on the neurodevelopment and microbiome of cesarean-born infants: A blinded randomized controlled trial. (July 14, 2025)
• Empirical and biologically based models for cancer risk assessment. (July 14, 2025)
• Empirical approaches to risk estimation and prediction. (July 14, 1999)
• Environmental hazards: evidence for effects on child health. (July 14, 2025)
• Environmental health risk assessment: hexachlorobenzene. (July 14, 1986)
• Environmental lead level and pregnancy-induced hypertension. (March 1, 2006)
• Epidemiologic evidence of relationships between reproductive and child health outcomes and environmental chemical contaminants. (May 1, 2008)
• Epidemiology of pancreatic cancer: an overview. (July 14, 2025)
• Epidemiology of testicular cancer: an overview. (July 14, 2025)
• Epidemiology research. (July 14, 2025)
• Estimates of global mortality attributable to particulate air pollution using satellite imagery. (January 1, 2013)
• Estimates of the cancer burden in Europe from radioactive fallout from the Chernobyl accident. (July 14, 2025)
• Estimates of the number of liver carcinogens in bioassays conducted by the National Toxicology Program. (June 1, 1998)
• Estimates of the proportion of chemicals that were carcinogenic or anticarcinogenic in bioassays conducted by the National Toxicology Program. (January 1, 1999)
• Estimates of the proportions of carcinogens and anticarcinogens in bioassays conducted by the U.S. National Toxicology Program. Application of a new meta-analytic approach. (July 14, 1999)
• Ethical principles for regulatory risk decision-making. (June 1, 2025)
• Evaluating the effects of ambient air pollution on life expectancy. (July 14, 2025)
• Evaluation of regression calibration and SIMEX methods in logistic regression when one of the predictors is subject to additive measurement error. (July 14, 1999)
• Evaluation of the United States COVID-19 vaccine allocation strategy. (July 14, 2025)
• Evolution of computed tomography angiography spot sign is consistent with a site of active hemorrhage in acute intracerebral hemorrhage. (January 1, 2014)
• Expert elicitation for the judgment of prion disease risk uncertainties. (July 14, 2025)
• Expert elicitation on the uncertainties associated with chronic wasting disease. (July 14, 2025)
• Exploring bias in a generalized additive model for spatial air pollution data. (August 1, 2003)
• Exposure of mice to arsenic and/or benzo[a]pyrene does not increase the frequency of Aprt-deficient cells recovered from explanted skin of Aprt heterozygous mice. (June 1, 2006)
• Exposure to drinking water trihalomethanes and nitrate and the risk of brain tumours in young people. (September 1, 2021)
• Exposure to environmental tobacco smoke (ETS) and risk of lung cancer in Montreal: a case-control study. (July 14, 2025)
• Exposure to loud noise and risk of vestibular schwannoma: results from the INTERPHONE international case‒control study. (July 14, 2025)
• Exposure to Medical Radiation during Fetal Life, Childhood and Adolescence and Risk of Brain Tumor in Young Age: Results from The MOBI-Kids Case-Control Study. (July 14, 2025)
• Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight. (May 1, 2011)
• Exposures in the Indoor Environment and Prevalence of Allergic Conditions in the United States of America. (July 14, 2025)
• Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality. (May 1, 2009)
• External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality. (July 14, 2025)
• FDA-iRISK--a comparative risk assessment system for evaluating and ranking food-hazard pairs: case studies on microbial hazards. (March 1, 2013)
• Feasibility and Preliminary Results of Effectiveness of Social Media-based Intervention on the Psychological Well-being of Suspected COVID-19 Cases during Quarantine. (October 1, 2020)
• Fine particulate air pollution and all-cause mortality within the Harvard Six-Cities Study: variations in risk by period of exposure. (November 1, 2002)
• Fine Particulate Air Pollution and Mortality: Response to Enstrom's Reanalysis of the American Cancer Society Cancer Prevention Study II Cohort. (July 14, 2025)
• First analysis of cancer incidence and occupational radiation exposure based on the National Dose Registry of Canada. (July 14, 2025)
• First analysis of mortality and occupational radiation exposure based on the National Dose Registry of Canada. (July 14, 2025)
• Flexible modeling of exposure-response relationship between long-term average levels of particulate air pollution and mortality in the American Cancer Society study. (July 14, 2025)
• Future perspectives, unresolved issues and research needs. (July 14, 1999)
• Gaseous air pollutants and asthma hospitalization of children with low household income in Vancouver, British Columbia, Canada. (July 14, 2025)
• Gastroschisis in Ontario, Canada: 2012-2018. (July 14, 2025)
• Gender-related differences in the association between socioeconomic status and self-reported diabetes. (June 1, 2003)
• Genetic variation associated with the occurrence and progression of neurological disorders. (July 1, 2017)
• Global estimates of mortality associated with long-term exposure to outdoor fine particulate matter. (July 14, 2025)
• Guidelines for the communication of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop. (August 1, 2008)
• Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop. (August 1, 2008)
• Has the Objective Quality of Evidence in Imaging Papers Changed Over the Last 20 Years? (August 1, 2018)
• Health and air quality: directions for policy-relevant research. (July 14, 2025)
• Health effects associated with exposure to ambient air pollution. (July 14, 2025)
• Health effects of radon: a review of the literature. (January 1, 2009)
• Health outcomes of low-dose ionizing radiation exposure among medical workers: a cohort study of the Canadian national dose registry of radiation workers. (July 14, 2025)
• Health risk perceptions as mediators of socioeconomic differentials in health behaviour. (November 1, 2008)
• Health risks of electromagnetic fields. Part I: Evaluation and assessment of electric and magnetic fields. (July 14, 2025)
• Health risks of electromagnetic fields. Part II: Evaluation and assessment of radio frequency radiation. (July 14, 2025)
• Health risks of electromagnetic fields. Part III: Risk analysis. (July 14, 2025)
• Hearing loss prevalence and hearing health among school-aged children in the Canadian Arctic. (July 1, 2021)
• High Rate of Medical Emergency Team Activation in Children with Tracheostomy. (March 1, 2020)
• High-performance liquid chromatography method for determination of N-glucuronidation of 4-aminobiphenyl by mouse, rat, and human liver microsomes. (July 14, 2025)
• Higher cesarean delivery rates are associated with higher infant mortality rates in industrialized countries. (March 1, 2015)
• Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. (July 14, 2025)
• Hyperactive spruce budworm antifreeze protein expression in transgenic Drosophila does not confer cold shock tolerance. (August 1, 2004)
• Identification of public health priorities, barriers, and solutions for Kuwait using the modified Delphi method for stakeholder consensus. (September 1, 2021)
• Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. (July 1, 2017)
• Impact of particulate air pollution on quality-adjusted life expectancy in Canada. (July 14, 2025)
• Impacts of operative delivery for the first twin on neonatal outcomes in the second twin. (October 1, 2006)
• Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. (July 14, 2025)
• In utero exposure in chronic toxicity/carcinogenicity studies. (June 1, 1981)
• In utero pesticide exposure and childhood morbidity. (January 1, 2007)
• Incidence of major depression diagnoses in the Canadian Armed Forces: longitudinal analysis of clinical and health administrative data. (May 1, 2020)
• Increased effects of smoking and obesity on asthma among female Canadians: the National Population Health Survey, 1994-1995. (July 14, 2025)
• Increased Mortality and Length of Stay Associated With Medical Emergency Team Review in Hospitalized Pediatric Patients: A Retrospective Cohort Study. (June 1, 2017)
• Influence of relatively low level of particulate ar pollution on hospitalization for COPD in elderly people. (January 1, 2004)
• Injury and infection in dental clinics: Risk factors and prevention. (September 1, 2018)
• Injury surveillance in Trinidad: an accident and emergency based injury surveillance system at the San Fernando General Hospital. (March 1, 2009)
• Interaction between two carcinogens in the two-stage clonal expansion model of carcinogenesis. (July 14, 2025)
• Interactions between cigarette smoking and ambient PM(2.5) for cardiovascular mortality. (April 1, 2017)
• Interactions between cigarette smoking and fine particulate matter in the Risk of Lung Cancer Mortality in Cancer Prevention Study II. (July 14, 2025)
• Interactions between occupational exposure to extremely low frequency magnetic fields and chemicals for brain tumour risk in the INTEROCC study. (November 1, 2017)
• Intermediate CAG repeat expansion in the ATXN2 gene is a unique genetic risk factor for ALS--a systematic review and meta-analysis of observational studies. (July 14, 2025)
• International case studies of psychosocial ripple effects of bovine spongiform encephalopathy (BSE) in European countries. (July 14, 2025)
• International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper No. 3. The concept of negativity in experimental carcinogenesis. (May 1, 1986)
• International perspectives on air quality: risk management principles for policy development--conference statement. (July 14, 2025)
• INTEROCC case-control study: lack of association between glioma tumors and occupational exposure to selected combustion products, dusts and other chemical agents. (July 14, 2025)
• Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials. (July 14, 2025)
• Interspecies extrapolation of toxicity data. (June 1, 1992)
• Interventions for COVID-19 Vaccine Hesitancy: A Systematic Review and Narrative Synthesis. (July 14, 2025)
• Introduction of the hematotoxicity modeling workshop. (November 1, 2000)
• Investigation of bias related to differences between case and control interview dates in five INTERPHONE countries. (December 1, 2016)
• Is Immigrant Status Associated With Cervical Cancer Screening Among Women in Canada? Results From a Cross-Sectional Study. (June 1, 2019)
• Is there a safe level of exposure to a carcinogen? (July 14, 2025)
• Ischemic Heart Disease Mortality and Long-Term Exposure to Source-Related Components of U.S. Fine Particle Air Pollution. (June 1, 2016)
• Isolation and characterization of a dihydrofolate reductase gene mutation in methotrexate-resistant Drosophila cells. (July 14, 1996)
• Key attributes of health and environmental risk decision-making: A scoping review. (July 14, 2025)
• Key characteristics of 86 agents known to cause cancer in humans. (July 14, 2025)
• Leisure-time energy expenditure in asthmatics and non-asthmatics. (January 1, 2001)
• Levels of cadmium in human kidney cortex in Canada. (July 14, 2025)
• Lifetime occupational exposure to metals and welding fumes, and risk of glioma: a 7-country population-based case-control study. (July 14, 2025)
• Liver cancers in Mayak workers. (September 1, 2000)
• Locus-of-care disparities in end-of-life care intensity among adolescents and young adults with cancer: A population-based study using the IMPACT cohort. (July 14, 2025)
• Locust retinoid X receptors: 9-Cis-retinoic acid in embryos from a primitive insect. (July 14, 2025)
• Long- and medium-term carcinogenicity studies in animals and short-term genotoxicity tests. (July 14, 1999)
• Long-term ambient fine particulate matter air pollution and lung cancer in a large cohort of never-smokers. (July 14, 2025)
• Long-Term Care Ownership and Operator Factors in Probable Delirium: A Population-Based Study from Ontario, Canada. (July 14, 2025)
• Long-term cognitive impairment after probable delirium in long-term care residents: A population-based retrospective cohort study. (April 1, 2024)
• Long-Term Ozone Exposure and Mortality in a Large Prospective Study. (July 14, 2025)
• Long-term ozone exposure and mortality. (July 14, 2025)
• Long-term toxicity of hexachlorobenzene in the rat and the effect of dietary vitamin A. (September 1, 1985)
• Long-term toxicity of hexachlorobenzene. (February 1, 1988)
• Low dose ionizing radiation exposure and cardiovascular disease mortality: cohort study based on Canadian national dose registry of radiation workers. (July 14, 2025)
• Low radon exposures and lung cancer risk: joint analysis of the Czech, French, and Beaverlodge cohorts of uranium miners. (July 1, 2019)
• Lung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke: shape of the exposure-response relationships. (November 1, 2011)
• Lung cancer in Mayak workers. (November 1, 2004)
• Lung cancer mortality among male nuclear workers of the Mayak facilities in the former Soviet Union. (July 1, 2000)
• Lung cancer mortality among nuclear workers of the Mayak facilities in the former Soviet Union. An updated analysis considering smoking as the main confounding factor. (July 1, 2003)
• Lung cancer risk due to exposure to incorporated plutonium. (April 1, 1998)
• Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. (July 14, 2025)
• Lung Volume Recruitment and Quality of Life in Duchenne Muscular Dystrophy: Secondary Analysis of the STEADFAST Randomized Controlled Trial. (July 14, 2025)
• Lung, liver and bone cancer mortality in Mayak workers. (July 14, 2025)
• Magnetic resonance imaging T1 indices of the brain as biomarkers of inhaled manganese exposure. (May 1, 2022)
• Malignant neoformations of the hematopoietic and lymphoid tissues in the personnel of the 1st plant of atomic industry. (July 14, 1991)
• Management of natural and bioterrorism induced pandemics. (September 1, 2007)
• Managing health risks from drinking water--a report to the Walkerton inquiry. (July 14, 2025)
• Managing the microbiological risks of drinking water. (July 14, 2025)
• Manganese showcase symposium. (January 1, 2017)
• Maternal and neonatal outcomes in women undergoing Roux-en-Y gastric bypass: A systematic review and meta-analysis. (September 1, 2021)
• Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population. (March 1, 2008)
• Maternal cigarette smoking and the risk of pregnancy-induced hypertension and eclampsia. (April 1, 2006)
• Maternal exposure to moderate ambient carbon monoxide is associated with decreased risk of preeclampsia. (July 1, 2012)
• Mathematical Models for Estimating the Risks of Bovine Spongiform Encephalopathy (BSE). (July 14, 2025)
• Measuring carcinogenic potency. (December 1, 1990)
• Mechanisms of carcinogenesis and biologically based models for estimation and prediction of risk. (July 14, 1999)
• Melatonin to prevent delirium in patients with advanced cancer: a double blind, parallel, randomized, controlled, feasibility trial. (July 14, 2025)
• Men having sex with men donor deferral risk assessment: an analysis using risk management principles. (January 1, 2008)
• Mental Health Service Use in Depressed Military Personnel: A Systematic Review. (July 14, 2025)
• Mental Health Service Utilization in Depressed Canadian Armed Forces Personnel. (January 1, 2019)
• Metabolic syndrome and chronic disease. (February 1, 2014)
• Methods for detecting and estimating population threshold concentrations for air pollution-related mortality with exposure measurement error. (June 1, 1999)
• Methylmercury-induced mitochondrial DNA synthesis in neural tissue of cats. (April 1, 1985)
• Mining pharmacovigilance data using Bayesian logistic regression with James-Stein type shrinkage estimation. (September 1, 2010)
• Mitigating the externality of diseases of poverty through health aid. (October 1, 2021)
• Modeling seasonal behavior changes and disease transmission with application to chronic wasting disease. (July 14, 2025)
• Modeling seasonal variation in indoor radon concentrations. (May 1, 2005)
• Modeling the Ames Salmonella/microsome assay. (June 1, 1993)
• Modeling the effect of lockdown timing as a COVID-19 control measure in countries with differing social contacts. (July 14, 2025)
• Modeling the Impact of Climate Change on Cervid Chronic Wasting Disease in Semi-Arid South Texas. (July 14, 2025)
• Modeling the public health system response to a terrorist event in the food supply. (November 1, 2009)
• Modeling U-shaped dose-response curves for manganese using categorical regression. (January 1, 2017)
• Modeling U-Shaped Exposure-Response Relationships for Agents that Demonstrate Toxicity Due to Both Excess and Deficiency. (February 1, 2017)
• Modeling U-Shaped Exposure-Response Relationships for Agents that Demonstrate Toxicity Due to Both Excess and Deficiency. (July 14, 2025)
• Modelling community-control strategies to protect hospital resources during an influenza pandemic in Ottawa, Canada. (July 14, 2025)
• Mortality among personnel who worked at the Mayak complex in the first years of its operation. (July 1, 1996)
• Mortality among workers with chronic radiation sickness. (July 1, 1996)
• Mortality and long-term exposure to ambient air pollution: ongoing analyses based on the American Cancer Society cohort. (July 14, 2025)
• Multi-jurisdictional expert opinion for improving children's environmental health protection. (April 1, 2009)
• Mutagenicity screening of foods I. Results with beverages. (July 14, 1982)
• Mutagenicity screening of foods. II. Results with fruits and vegetables. (July 14, 1984)
• Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination: Insights from a Pharmacovigilance Perspective. (July 14, 2025)
• National assessment of Canadian pandemic preparedness: Employing InFluNet to identify high-risk areas for inter-wave vaccine distribution. (August 1, 2017)
• Neck circumference percentile: A screening tool for pediatric obstructive sleep apnea. (February 1, 2015)
• Neonatal death and morbidity in vertex-nonvertex second twins according to mode of delivery and birth weight. (March 1, 2005)
• Neonatal mortality and morbidity in vertex-vertex second twins according to mode of delivery and birth weight. (July 14, 2025)
• Neonatal necrotizing enterocolitis: a case series examining clinical diagnosis with discrepant versus concordant autopsy results. (June 1, 2020)
• Neuropathology, tremor and electromyogram in rats exposed to manganese phosphate/sulfate mixture. (July 14, 2025)
• New directions in toxicity testing. (July 14, 2025)
• No association between metoclopramide treatment in ED and reduced risk of post-concussion headache. (December 1, 2018)
• Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson's Disease. (July 14, 2025)
• Nonparticipation Selection Bias in the MOBI-Kids Study. (January 1, 2019)
• Nurse-Driven Clinical Pathway for Inpatient Asthma: A Randomized Controlled Trial. (April 1, 2017)
• Obesity may increase the incidence of asthma in women but not in men: longitudinal observations from the Canadian National Population Health Surveys. (July 14, 2025)
• Obstetric healthcare providers' perceptions of communicating gestational weight gain recommendations to overweight/obese pregnant women. (December 1, 2012)
• Obstructive sleep apnea and hypertension in pediatric chronic kidney disease. (November 1, 2019)
• Occupational exposure to extremely low-frequency magnetic fields and brain tumor risks in the INTEROCC study. (September 1, 2014)
• Occupational exposure to high-frequency electromagnetic fields and brain tumor risk in the INTEROCC study: An individualized assessment approach. (October 1, 2018)
• Occupational exposure to metals and risk of meningioma: a multinational case-control study. (December 1, 2016)
• Occupational exposure to radiofrequency electromagnetic fields and brain tumor risk: Application of the INTEROCC job-exposure matrix. (July 14, 2025)
• Occupational exposure to radiofrequency electromagnetic fields and brain tumor risk: Application of the INTEROCC job-exposure matrix. (July 14, 2025)
• Occupational solvent exposure and risk of glioma in the INTEROCC study. (July 14, 2025)
• Occupational solvent exposure and risk of meningioma: results from the INTEROCC multicentre case-control study. (April 1, 2014)
• Occupations and lung cancer: a population-based case-control study in British Columbia. (July 14, 2025)
• Occurrence and clinical predictors of operative delivery for the vertex second twin after normal vaginal delivery of the first twin. (January 1, 2005)
• Occurrence and determinants of trimethoprim/sulfamethoxazole use in pregnancy. (July 14, 2025)
• Off-label use of cancer therapies in women diagnosed with breast cancer in the United States. (July 14, 2025)
• On the relationship between time-series studies, dynamic population studies, and estimating loss of life due to short-term exposure to environmental risks. (July 1, 2003)
• On the use of historical control data to estimate dose response trends in quantal bioassay. (June 1, 1992)
• Open reduction internal fixation vs non-operative management in proximal humerus fractures: a prospective, randomized controlled trial protocol. (July 14, 2025)
• Optimal designs for estimating the effective dose in developmental toxicity experiments. (December 1, 2002)
• Options for basing Dietary Reference Intakes (DRIs) on chronic disease endpoints: report from a joint US-/Canadian-sponsored working group. (January 1, 2017)
• Overview of biological mechanisms of human carcinogens. (July 14, 2025)
• Overview of REACH: Issues Involved in the Registration of Metals. (March 1, 2021)
• Overview of the reanalysis of the Harvard Six Cities Study and American Cancer Society Study of Particulate Air Pollution and Mortality. (July 14, 2025)
• Overview, conclusions, and recommendations of the IPCS collaborative study on complex mixtures. (July 14, 2025)
• Paediatric reference intervals and curves for haemoglobin and ferritin: protocol for a systematic review and meta-analysis. (July 14, 2025)
• Paediatric Reference Intervals and Curves for Haemoglobin Estimated Using Direct Methods: A Systematic Review and Meta-Analysis. (August 1, 2025)
• Particulate air pollution standards and morbidity and mortality: case study. (July 14, 2025)
• Paternal age and adverse birth outcomes: teenager or 40+, who is at risk? (June 1, 2008)
• Patterns and prevalence of medication use across the menstrual cycle among healthy, reproductive aged women. (June 1, 2016)
• Patterns of cellular phone use among young people in 12 countries: Implications for RF exposure. (October 1, 2017)
• Patterns of Physical Activity and the Risk of Coronary Heart Disease: A Pilot Study. (July 14, 2025)
• Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population. (May 1, 2008)
• Personnel policy at regional level. (July 14, 2025)
• Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps. (September 1, 2014)
• Pharmacokinetics of methylmercury in the blood of monkeys (Macaca fascicularis). (January 1, 1989)
• Pharmacokinetics of oseltamivir phosphate and oseltamivir carboxylate in non-pregnant and pregnant rhesus monkeys. (April 1, 2020)
• Phenome-wide association study of genetically predicted B vitamins and homocysteine biomarkers with multiple health and disease outcomes: analysis of the UK Biobank. (March 1, 2023)
• Physical activity and non-movement behaviours: their independent and combined associations with metabolic syndrome. (July 14, 2025)
• Physical activity levels, pulmonary function, and MRI in children born extremely preterm: A comparison between children with and without bronchopulmonary dysplasia. (May 1, 2023)
• Physical inactivity and socioeconomic status in Canadian adolescents. (July 14, 2025)
• Physiological pharmacokinetics and cancer risk assessment. (July 14, 2025)
• Placenta previa: its relationship with race and the country of origin among Asian women. (July 14, 2025)
• Plasma concentrations of neurotransmitters and postpartum depression. (July 14, 2025)
• Polysomnography parameters as predictors of respiratory adverse events following adenotonsillectomy in children. (July 14, 2025)
• Population pharmacokinetics of 17alpha-hydroxyprogesterone caproate in singleton gestation. (October 1, 2016)
• Potential health risks of radiofrequency fields from wireless telecommunication devices. (July 14, 2025)
• Potentially Inappropriate Prescribing in Long-Term Care and its Relationship With Probable Delirium. (January 1, 2024)
• Practice variation in the management of children hospitalized with bronchiolitis: A Canadian perspective. (August 1, 2019)
• Pre- and post-conception pesticide exposure and the risk of birth defects in an Ontario farm population. (August 1, 2008)
• Predictors of adherence to positive airway pressure therapy in children: a systematic review and meta-analysis. (May 1, 2020)
• Predictors of postoperative respiratory complications in children undergoing adenotonsillectomy. (July 14, 2025)
• Preface-Prion research in perspective IV. (July 14, 2025)
• Preface. Prion research in perspective III. (July 14, 2025)
• Preface. Prion research in perspective. (July 14, 2025)
• Prevalence and associated factors for needlestick and sharp injuries (NSIs) among dental assistants in Jeddah, Saudi Arabia. (July 14, 2025)
• Prevalence and risk factors of musculoskeletal symptoms among dental students and dental practitioners in Riyadh City, Saudi Arabia. (July 14, 2025)
• Prevalence and the predictive performance of the dynamic CT-angiography spot sign in an observational cohort with intracerebral hemorrhage. (July 14, 2025)
• Prevalence of eczema between cesarean-born and vaginal-born infants within 1 year of age: a systematic review and meta-analysis. (June 1, 2022)
• Prevalence of Post-Traumatic Stress Disorder Following Caesarean Section: A Systematic Review and Meta-Analysis. (February 1, 2020)
• Principles of risk decision-making. (July 14, 2025)
• Principles, applications, risks and benefits of therapeutic hyperthermia. (July 14, 2025)
• Prion research in perspective. Preface. (July 14, 2025)
• Prionet Canada: a network of centres of excellence for research into prions and prion diseases. (July 14, 2025)
• PrioNet Canada: a network of centres of excellence for research on prion diseases--ongoing and future research directions. (July 14, 2025)
• Probabilistic Multiple-Bias Modeling Applied to the Canadian Data From the Interphone Study of Mobile Phone Use and Risk of Glioma, Meningioma, Acoustic Neuroma, and Parotid Gland Tumors. (July 14, 2025)
• Probable Delirium and Associated Patient Characteristics in Long-Term Care and Complex Continuing Care: A Population-Based Observational Study. (January 1, 2022)
• Procedures for calculating benchmark doses for health risk assessment. (October 1, 1998)
• Projection of residential radon lung cancer risks: the Beir VI risk models. (July 14, 2025)
• Prostate volume estimations using magnetic resonance imaging and transrectal ultrasound compared to radical prostatectomy specimens. (August 1, 2016)
• Public health benefits of strategies to reduce greenhouse-gas emissions: health implications of short-lived greenhouse pollutants. (July 14, 2025)
• Pulmonary Magnetic Resonance Imaging of Ex-Preterm Children with and without Bronchopulmonary Dysplasia. (July 1, 2022)
• Quantifying the health impacts of ambient air pollutants: recommendations of a WHO/Europe project. (July 1, 2015)
• Quantitative factors in chemical carcinogenesis: variation in carcinogenic potency. (August 1, 1990)
• Radiotherapy after radical prostatectomy: treatment recommendations differ between urologists and radiation oncologists. (July 14, 2025)
• Radon and COPD mortality in the American Cancer Society Cohort. (May 1, 2012)
• Radon and lung cancer in the American Cancer Society cohort. (March 1, 2011)
• Radon and nonrespiratory mortality in the American Cancer Society cohort. (July 14, 2025)
• Radon interventions around the globe: A systematic review. (May 1, 2019)
• Radon, an invisible killer in Canadian homes: perceptions of Ottawa-Gatineau residents. (April 1, 2019)
• Radon, cigarette smoke, and lung cancer: a re-analysis of the Colorado Plateau uranium miners' data. (May 1, 1993)
• Randomized controlled trial: effects of diet on DNA damage in heavy smokers. (May 1, 2006)
• Reanalysis of the Harvard Six Cities Study, part I: validation and replication. (July 14, 2025)
• Reanalysis of the Harvard Six Cities Study, part II: sensitivity analysis. (July 14, 2025)
• Recall bias in the assessment of exposure to mobile phones. (May 1, 2009)
• Recall of mobile phone usage and laterality in young people: The multinational Mobi-Expo study. (August 1, 2018)
• Recent Advances in Probabilistic Dose-Response Assessment to Inform Risk-Based Decision Making. (April 1, 2021)
• Recent advances in research on radiofrequency fields and health: 2001-2003. (July 14, 2025)
• Recent advances in research on radiofrequency fields and health: 2004-2007. (April 1, 2009)
• Recent advances in research on radiofrequency fields and health. (July 14, 2025)
• Recent bioassay results on coal tars and benzo(a)pyrene: implications for risk assessment. (October 1, 1998)
• Recent developments in carcinogenic risk assessment. (July 14, 1989)
• Recent oral contraceptive use and adverse birth outcomes. (May 1, 2009)
• RecoverNow: Feasibility of a Mobile Tablet-Based Rehabilitation Intervention to Treat Post-Stroke Communication Deficits in the Acute Care Setting. (July 14, 2025)
• Reducing the Harm of Prostate Cancer Screening: Repeated Prostate-Specific Antigen Testing. (January 1, 2016)
• Regulatory and nonregulatory strategies for improving children's environmental health in Canada. (July 14, 2025)
• Relationship between asthma prevalence and income among Canadians. (July 14, 2025)
• Relationships between fine particulate air pollution, cardiometabolic disorders, and cardiovascular mortality. (July 14, 2025)
• Relevance and feasibility of principles for health and environmental risk decision-making. (July 14, 2025)
• Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. (December 1, 2014)
• Research gaps and priorities for quantitative microbial risk assessment (QMRA). (November 1, 2024)
• Residential ambient benzene exposure in the United States and subsequent risk of hematologic malignancies. (July 14, 2025)
• Residential pesticides and childhood leukemia: a systematic review and meta-analysis. (January 1, 2010)
• Residential pesticides and childhood leukemia: a systematic review and meta-analysis. (March 1, 2011)
• Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. (March 1, 2005)
• Residential radon exposure and risk of incident hematologic malignancies in the Cancer Prevention Study-II Nutrition Cohort. (July 1, 2016)
• Residential radon in Canada: an uncertainty analysis of population and individual lung cancer risk. (April 1, 2005)
• Resolved: biologically based models are useful for analyzing radiation epidemiological data. Pro. (December 1, 2000)
• Response to "Quantifying the health impacts of ambient air pollutants: methodological errors must be avoided". (April 1, 2016)
• Response to: Premature deaths attributed to ambient air pollutants: let us interpret the Robins-Greenland theorem correctly. (April 1, 2017)
• Retrospective data quality audits of the Harvard Six Cities and American Cancer Society studies. (July 14, 2025)
• Reversibility of ethylenethiourea-induced thyroid lesions. (February 1, 1983)
• Review of epidemiological and toxicological studies on health effects from ingestion of asbestos in drinking water. (November 1, 2024)
• Review of non-invasive biomarkers as a tool for exposure characterization in human health risk assessments. (July 14, 2025)
• Review of the etiology of breast cancer with special attention to organochlorines as potential endocrine disruptors. (March 1, 2008)
• Reviewing the History of Pandemic Influenza: Understanding Patterns of Emergence and Transmission. (July 14, 2025)
• Risk assessment and regulatory decision making. (October 1, 1981)
• Risk assessment practice for essential metals. (July 14, 2025)
• Risk communication of endocrine-disrupting chemicals: improving knowledge translation and transfer. (March 1, 2008)
• Risk factors associated with the onset and progression of Alzheimer's disease: A systematic review of the evidence. (July 1, 2017)
• Risk factors for ovarian cancer: an overview with emphasis on hormonal factors. (March 1, 2008)
• Risk factors for respiratory adverse events after adenoidectomy and tonsillectomy in children with down syndrome: a retrospective cohort study. (June 1, 2022)
• Risk management frameworks for human health and environmental risks. (July 14, 2025)
• Risk of Adverse Cardiovascular Events Following a Myocardial Infarction in Patients Receiving Combined Clopidogrel and Proton Pump Inhibitor Treatment: A Nested Case-Control Study. (September 1, 2020)
• Risk of brain tumours in relation to estimated RF dose from mobile phones: results from five Interphone countries. (September 1, 2011)
• Risk of early childhood overweight/obesity following cesarean section: A systematic review and meta-analysis. (July 14, 2025)
• Risk of endometrial cancer in relationship to cigarette smoking: results from the EPIC study. (July 14, 2025)
• Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients. (March 1, 2014)
• Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations. (July 14, 2025)
• Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis. (July 14, 2025)
• Risk Perception and Disaster Preparedness in Immigrants and Canadian-Born Adults: Analysis of a National Survey on Similarities and Differences. (December 1, 2017)
• Risk-based decision-making for blood safety: preliminary report of a consensus conference. (November 1, 2011)
• Role of epidemiology in health risk assessment. (July 14, 1990)
• Routine lung volume recruitment in boys with Duchenne muscular dystrophy: a randomised clinical trial. (August 1, 2022)
• Saccharin: a toxicological and historical perspective. (July 14, 2025)
• Safety surveillance of respiratory syncytial virus (RSV) vaccine among pregnant individuals: a real-world pharmacovigilance study using the Vaccine Adverse Event Reporting System. (July 14, 2025)
• Scoping Review of the Potential Health Effects of Exposure to Extremely Low-Frequency Electric and Magnetic Fields. (July 14, 2025)
• Selection of ecologic covariates in the American Cancer Society study. (July 14, 2025)
• Self-reported musculoskeletal symptoms among dentists in Saudi Arabia. (July 14, 2025)
• Self-reported musculoskeletal symptoms among dentists in Saudi Arabia. (July 14, 2025)
• Seven newly discovered intron positions in the triose-phosphate isomerase gene: evidence for the introns-late theory. (July 14, 2025)
• Severity scoring of manganese health effects for categorical regression. (January 1, 2017)
• Sex-related interactive effect of smoking and household pets on asthma incidence. (November 1, 2002)
• Should we screen aging physicians for cognitive decline? (July 14, 2025)
• Significance is not sufficient. (November 1, 2017)
• Social determinants of health among residential areas with a high tuberculosis incidence in a remote Inuit community. (May 1, 2019)
• Sont et al. Respond to "Studies of Workers Exposed to Low Doses of Radiation". (July 14, 2025)
• Sources of variation in the mutagenic potency of complex chemical mixtures based on the Salmonella/microsome assay. (July 14, 2025)
• Spatial analysis for environmental health research: concepts, methods, and examples. (July 14, 2025)
• Spatial analysis of air pollution and mortality in California. (July 14, 2025)
• Spatial analysis of air pollution and mortality in Los Angeles. (November 1, 2005)
• Spatial analysis of the air pollution-mortality relationship in the context of ecologic confounders. (July 14, 2025)
• Spatial regression models for large-cohort studies linking community air pollution and health. (July 14, 2025)
• Specific fatty acid intake and the risk of pancreatic cancer in Canada. (July 14, 2025)
• Spinal pain and major depression in a military cohort: bias analysis of dependent misclassification in electronic medical records. (March 1, 2022)
• Statistical analysis of lacZ mutant frequency data from MutaMouse mutagenicity assays. (May 1, 1998)
• Statistical analysis of the lacI transgenic mouse mutagenicity assay. (July 14, 2025)
• Statistical considerations in the interpretation of negative carcinogenicity data. (February 1, 1989)
• Statistical issues in the analysis of the long-term carcinogenicity bioassay in small rodents: an empirical evaluation of statistical decision rules. (February 1, 1989)
• Statistical methods for active pharmacovigilance, with applications to diabetes drugs. (July 14, 2025)
• Statistical methods in cancer research. Volume III--The design and analysis of long-term animal experiments. (July 14, 1986)
• Strategies for clean air and health. (July 14, 2025)
• Strategies to improve chemical-related risk communication in Canada. (October 1, 2010)
• Structure-function relationships in spruce budworm antifreeze protein revealed by isoform diversity. (October 1, 2000)
• Studies on the Mayak nuclear workers: health effects. (March 1, 2002)
• Studies on the Ozyorsk population: health effects. (March 1, 2002)
• Survey of public perceptions of prion disease risks in Canada: what does the public care about? (July 14, 2025)
• Systematic review and meta-analysis of adverse cardiovascular events associated with proton pump inhibitors used alone or in combination with antiplatelet agents. (March 1, 2019)
• Systematic review in evidence-based risk assessment. (October 3, 2025)
• Systematic review in evidence-based risk assessment. (July 14, 2025)
• Systematic review of epidemiological and toxicological evidence on health effects of fluoride in drinking water. (January 1, 2024)
• Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts. (October 1, 2014)
• Systematic reviews of factors associated with the onset and progression of neurological conditions in humans: A methodological overview. (July 1, 2017)
• Systemic quinolones and risk of acute liver failure I: Analysis of data from the US FDA adverse event reporting system. (July 1, 2021)
• Systemic quinolones and risk of acute liver failure III: A nested case-control study using a US electronic health records database. (August 1, 2021)
• Systemic quinolones and risk of retinal detachment I: analysis of data from the US FDA adverse event reporting system. (February 1, 2022)
• Systemic quinolones and risk of retinal detachment III: a nested case-control study using a US electronic health records database. (June 1, 2022)
• Taima (stop) TB: the impact of a multifaceted TB awareness and door-to-door campaign in residential areas of high risk for TB in Iqaluit, Nunavut. (July 14, 2025)
• Technical guide for applications of gene expression profiling in human health risk assessment of environmental chemicals. (July 1, 2015)
• Testicular cancer and hormonally active agents. (March 1, 2008)
• Testing the harvesting hypothesis by time-domain regression analysis. I: baseline analysis. (July 14, 2025)
• Testing the harvesting hypothesis by time-domain regression analysis. II: covariate effects. (July 14, 2025)
• Tests for trend in developmental toxicity experiments with correlated binary data. (August 1, 1994)
• The antifreeze potential of the spruce budworm thermal hysteresis protein. (September 1, 1997)
• The application of PBPK models in estimating human brain tissue manganese concentrations. (January 1, 2017)
• The association between ambient carbon monoxide levels and daily mortality in Toronto, Canada. (August 1, 1998)
• The Association Between Doula Care and Childbirth-Related Post-Traumatic Stress Disorder Symptoms: The Mediating Role of Childbirth Experience. (June 1, 2025)
• The association between social support and postpartum post-traumatic stress disorder. (July 14, 2025)
• The association between sulfate air pollution and mortality at the county scale: an exploration of the impact of scale on a long-term exposure study. (July 14, 2025)
• The Critical Century Manifesto (November 9, 2025)
• The development of respondent-driven sampling (RDS) inference: A systematic review of the population mean and variance estimates. (July 14, 2025)
• The effect of censoring on cancer risk estimates based on the Canadian National Dose Registry of occupational radiation exposure. (September 1, 2005)
• The effect of coarse ambient particulate matter on first, second, and overall hospital admissions for respiratory disease among the elderly. (November 1, 2005)
• The effect of concurvity in generalized additive models linking mortality to ambient particulate matter. (January 1, 2003)
• The effects of lysine analogs during pelvic surgery: a systematic review and meta-analysis. (July 1, 2014)
• The effects of recall errors and of selection bias in epidemiologic studies of mobile phone use and cancer risk. (July 1, 2006)
• The Effects of Traditional Chinese Medicine as an Auxiliary Treatment for COVID-19: A Systematic Review and Meta-Analysis. (March 1, 2021)
• The future of mechanistic research in risk assessment: where are we going and can we get there from here? (July 14, 2025)
• The future of toxicity testing. (February 1, 2010)
• The Global Landscape of Occupational Exposure Limits--Implementation of Harmonization Principles to Guide Limit Selection. (July 14, 2025)
• The Impact of a Maternal Education Program Through Text Messaging in Rural China: Cluster Randomized Controlled Trial. (July 14, 2025)
• The impact of adverse childhood experiences on postpartum post-traumatic stress disorder in women: A prospective cohort study in China. (March 1, 2025)
• The impact of pregnancy on postoperative outcomes among obese women who underwent bariatric surgery: A systematic review and meta-analysis. (September 1, 2020)
• The impact of social amplification and attenuation of risk and the public reaction to mad cow disease in Canada. (May 1, 2009)
• The implementation of rifapentine and isoniazid (3HP) in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP study. (December 1, 2020)
• The incidence and prevalence of delirium across palliative care settings: A systematic review. (September 1, 2019)
• The incidence of post-traumatic stress disorder following traumatic childbirth: A systematic review and meta-analysis. (July 1, 2023)
• The Incidence of Postpartum Post-Traumatic Stress Disorder in Women Exposed to Adverse Childhood Experiences: A Systematic Review and Meta-Analysis. (March 1, 2025)
• The influence of ambient coarse particulate matter on asthma hospitalization in children: case-crossover and time-series analyses. (June 1, 2002)
• The influence of the environment and other exogenous agents on spontaneous abortion risk. (March 1, 2008)
• The INTEROCC case-control study: risk of meningioma and occupational exposure to selected combustion products, dusts and other chemical agents. (January 1, 2018)
• The INTERPHONE study: design, epidemiological methods, and description of the study population. (July 14, 2025)
• The Intracranial Distribution of Gliomas in Relation to Exposure From Mobile Phones: Analyses From the INTERPHONE Study. (July 14, 2025)
• The legal awareness of medical workers in the system of medical care quality management. (July 14, 2025)
• The MOBI-Kids Study Protocol: Challenges in Assessing Childhood and Adolescent Exposure to Electromagnetic Fields from Wireless Telecommunication Technologies and Possible Association with Brain Tumor Risk. (July 14, 2025)
• The Next Generation of Risk Assessment Multi-Year Study-Highlights of Findings, Applications to Risk Assessment, and Future Directions. (November 1, 2016)
• The Palliative Management of Refractory Cirrhotic Ascites Using the PleurX ((c)) Catheter. (July 14, 2025)
• The power and interpretation of the carcinogenicity bioassay. (December 1, 1983)
• The prevalence of food allergy in cesarean-born children aged 0-3 years: A systematic review and meta-analysis of cohort studies. (July 14, 2025)
• The preventative role of exogenous melatonin administration to patients with advanced cancer who are at risk of delirium: study protocol for a randomized controlled trial. (July 14, 2025)
• The psychosocial and socioeconomic consequences of bovine spongiform encephalopathy (BSE): a community impact study. (July 14, 2025)
• The REACH registration process: A case study of metallic aluminium, aluminium oxide and aluminium hydroxide. (March 1, 2021)
• The risk to human islet cell transplant recipients of acquiring variant Creutzfeldt-Jakob disease: a provisional quantitative risk assessment. (July 14, 2025)
• The role of particulate size and chemistry in the association between summertime ambient air pollution and hospitalization for cardiorespiratory diseases. (June 1, 1997)
• The spatial association between community air pollution and mortality: a new method of analyzing correlated geographic cohort data. (June 1, 2001)
• The use of biologically based cancer risk models in radiation epidemiology. (July 14, 2025)
• The use of categorical regression in modeling copper exposure-response relationships. (July 14, 2025)
• The use of categorical regression in the assessment of the risks of nutrient deficiency and excess. (July 14, 2025)
• The vision of toxicity testing in the 21st century: moving from discussion to action. (September 1, 2010)
• The Web-based CanMEDS Resident Learning Portfolio Project (WEBCAM): how we got started. (December 1, 2016)
• Thermal therapy, part 1: an introduction to thermal therapy. (July 14, 2025)
• Thermal therapy, part 2: hyperthermia techniques. (July 14, 2025)
• Thermal therapy, Part III: ablation techniques. (July 14, 2025)
• Thermal therapy, Part IV: electromagnetic and thermal dosimetry. (July 14, 2025)
• Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future. (January 1, 2018)
• Tobacco budworm dihydrofolate reductase is a promising target for insecticide discovery. (January 1, 2000)
• Towards a reconciliation of the introns early or late views: triosephosphate isomerase genes from insects. (July 14, 2025)
• Toxicity testing in the 21st century: a vision and a strategy. (February 1, 2010)
• Toxicity testing in the 21st century: bringing the vision to life. (February 1, 2009)
• Toxicity testing in the 21st century: implications for human health risk assessment. (April 1, 2009)
• Toxicity testing in the 21st century: progress in the past decade and future perspectives. (January 1, 2020)
• Toxicological procedures for assessing the carcinogenic potential of agricultural chemicals. (July 14, 1982)
• Toxicology studies. II. The laboratory animal. (December 1, 1979)
• Tranexamic Acid During Radical Cystectomy: A Randomized Clinical Trial. (July 14, 2025)
• Tranexamic Acid versus Placebo to Prevent Blood Transfusion during Radical Cystectomy for Bladder Cancer (TACT): Study Protocol for a Randomized Controlled Trial. (July 14, 2025)
• Tranexamic Acid versus Placebo to Prevent Blood Transfusion during Radical Cystectomy for Bladder Cancer (TACT): Study Protocol for a Randomized Controlled Trial. (July 14, 2025)
• Transcription of antifreeze protein genes in Choristoneura fumiferana. (August 1, 2007)
• Treatment for grade 4 peripheral intravenous infiltration with type 3 skin tears: A case report and literature review. (January 1, 2022)
• Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000-2016. (February 1, 2019)
• Trends in inpatient antiparkinson drug use in the USA, 2001-2012. (August 1, 2015)
• Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population. (December 1, 2013)
• Two stage model for carcinogenesis: number and size distributions of premalignant clones in longitudinal studies. (July 14, 2025)
• Two-generation chronic toxicity study with hexachlorobenzene in the rat. (July 14, 1986)
• Uncertainty and variability analysis in multiplicative risk models. (February 1, 1998)
• Uncertainty beyond probabilities of BSE: appraisals predicting worry and coping strategies in the Canadian public. (July 14, 2025)
• Uncertainty, variability, and sensitivity analysis in physiological pharmacokinetic models. (November 1, 1995)
• Understanding the experiences of lung volume recruitment among boys with Duchenne muscular dystrophy: A multicenter qualitative study. (January 1, 2023)
• Update on the provisional estimation of developing iatrogenic variant Creutzfeldt-Jakob disease from human islet cell transplantation procedures. (July 14, 2025)
• Use of generalized linear mixed models in analyzing mutant frequency data from the transgenic mouse assay. (July 14, 1998)
• Using a stochastic continuous-time Markov chain model to examine alternative timing and duration of the COVID-19 lockdown in Kuwait: what can be done now? (July 14, 2025)
• Using data on the uncertainty of LOAELs to model the probability of observing adverse effects in low-dose studies of the toxicity of chemical mixtures. (September 1, 2025)
• Using expert judgments to improve chronic wasting disease risk management in Canada. (July 14, 2025)
• Using Video Feedback Through Smartphone Instant Messaging in Fundamental Nursing Skills Teaching: Observational Study. (July 14, 2025)
• Using willingness to pay to evaluate the implementation of Canada's residential radon exposure guideline. (July 14, 2025)
• Utility gains from reductions in the modifiable burden of lung cancer attributable to residential radon in Canada. (August 1, 2018)
• Validation of mobile phone use recall in the multinational MOBI-kids study. (October 1, 2024)
• Validation of the Harvard Six Cities Study of particulate air pollution and mortality. (July 14, 2025)
• Value of Information Case Study on the Human Health and Economic Trade-offs Associated with the Timeliness, Uncertainty, and Costs of the Draft EPA Transcriptomic Assessment Product (ETAP) (July 1, 2024)
• Verification of occupational doses at the first nuclear plant in the former Soviet Union. (July 14, 2025)
• Vital signs after cardiac arrest following withdrawal of life-sustaining therapy: a multicenter prospective observational study. (November 1, 2014)
• When results from clinical trials are different from observational studies. (February 1, 2025)
• Wireless phone use in childhood and adolescence and neuroepithelial brain tumours: Results from the international MOBI-Kids study. (February 1, 2022)
• World Health Organization's International Radon Project. (April 1, 2006)